What happened to Hospira?
After Cutting Hundreds of Hospira-Related Jobs, Pfizer Sells Hospira Infusion Systems Biz in in $1 Billion Deal. Pfizer announced today it was selling its global infusion therapy business, Hospira Infusion Systems (HIS) to ICU Medical for $1 billion in cash and stock.
Is Hospira part of Viatris?
Pfizer’s biosimilar products, those internally developed by Pfizer and those acquired in Pfizer’s $17-billion acquisition of Hospira in 2015 as well as the hospital products acquired from Hospira, are not part of Viatris.
Is ICU Medical Hospira?
pumps, solutions, and devices that, when combined with the company’s existing businesses, makes ICU Medical one of the world’s leading pure-play infusion therapy companies. “We are pleased that Hospira Infusion Systems is now part of ICU Medical and welcome our new Hospira colleagues to the ICU team.
Where is Hospira headquarters located?
Lake Forest, IL
Hospira/Headquarters
Is Hospira a generic?
Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois….Hospira.
| Type | Subsidiary |
|---|---|
| Products | Generic acute-care and oncology injectables, integrated infusion therapy, medication management systems |
| Revenue | $4.5 billion (2014) |
Does Viatris make Viagra?
Products. The company produces and sells a variety of medicines, with 1,400 approved therapeutic molecules in its portfolio. It owns brands (like Viagra, Xanax, Lipitor), generics, including branded and complex generics, biosimilars, and over-the-counter (OTC) drugs and active pharmaceutical ingredients.
Does Pfizer own ICU Medical?
Upon completion of the transaction, which the companies expect to occur in the first quarter of 2017 subject to customary closing conditions including required regulatory approvals, Pfizer will own approximately 16.6 percent of ICU Medical.
Who bought ICU Medical?
Smiths Group
Almost all of the nearly 327 million Smiths Group shareholders voting on November 17 approved the $2.35 billion buy. Run out of the Minneapolis area, Smiths Medical’s business brings in more than $1 billion a year in revenue. It includes syringe and ambulatory infusion devices, vascular access and vital care products.
When did Abbott spin Hospira?
Abbott Laboratories said Monday that on April 30 it will officially spin off its global hospital products business Hospira Inc.
What does Mayne Pharma do?
Mayne Pharma Group Limited (Mayne Pharma) is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialize branded and generic pharmaceuticals. Mayne Pharma also provides contract development and manufacturing services to more than 125 clients worldwide.
What is Hospira used for?
Hospira’s products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. It was formerly the hospital products division of Abbott Laboratories.
How much did Pfizer make on Viagra?
Pfizer: Viagra revenue 2003-2019. Pfizer’s worldwide known erectile dysfunction product Viagra generated around 500 million U.S. dollars in revenue in 2019.
What does the company Hospira do?
Hospira, Inc. is a hospital products company that manufactures medication delivery systems, generic pharmaceuticals, and intensive care pharmaceuticals. Hospira’s pharmaceutical products include generic injectables used in areas such as anesthesia, cardiovascular, infectious diseases, and pain management.
What did Hospira do before Pfizer?
Before its acquisition by Pfizer, Hospira was the world’s largest producer of generic injectable pharmaceuticals, manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems.
Who are the competitors of hithospira?
Hospira’s competitors in specialty injectable pharmaceuticals include Fresenius AG, Baxter International Inc., Bedford Laboratories, Mylan, Sandoz, Teva Pharmaceuticals as well as divisions of several multinational pharmaceutical companies.
When did Hospira acquire TheraDoc?
In 2009, Hospira acquired the biotechnology business from Pliva-Croatia, the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $400 million, and TheraDoc, a clinical informatics company that develops hospital surveillance systems, in 2009.